Cargando…

Beneficial Effects of Vitamin D Treatment in an Obese Mouse Model of Non-Alcoholic Steatohepatitis

Serum vitamin D levels negatively correlate with obesity and associated disorders such as non-alcoholic steatohepatitis (NASH). However, the mechanisms linking low vitamin D (VD) status to disease progression are not completely understood. In this study, we analyzed the effect of VD treatment on NAS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jahn, Daniel, Dorbath, Donata, Kircher, Stefan, Nier, Anika, Bergheim, Ina, Lenaerts, Kaatje, Hermanns, Heike M., Geier, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356425/ https://www.ncbi.nlm.nih.gov/pubmed/30609782 http://dx.doi.org/10.3390/nu11010077

Ejemplares similares

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
por: Baumann, Anja, et al.
Publicado: (2020)

Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis
por: Sellmann, Cathrin, et al.
Publicado: (2017)

Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance
por: Sánchez, Victor, et al.
Publicado: (2021)

Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function
por: Brandt, Annette, et al.
Publicado: (2018)

Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children
por: Nier, Anika, et al.
Publicado: (2017)

Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase
por: Rajcic, Dragana, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern
por: Nier, Anika, et al.
Publicado: (2018)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Short‐Term Isocaloric Intake of a Fructose‐ but not Glucose‐Rich Diet Affects Bacterial Endotoxin Concentrations and Markers of Metabolic Health in Normal Weight Healthy Subjects
por: Nier, Anika, et al.
Publicado: (2019)

Metabolic Abnormalities in Normal Weight Children Are Associated with Increased Visceral Fat Accumulation, Elevated Plasma Endotoxin Levels and a Higher Monosaccharide Intake
por: Nier, Anika, et al.
Publicado: (2019)

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022)

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
por: Brandt, Annette, et al.
Publicado: (2019)

Exchanging dietary fat source with extra virgin olive oil does not prevent progression of diet-induced non-alcoholic fatty liver disease and insulin resistance
por: Rajcic, Dragana, et al.
Publicado: (2020)

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2021)

Semaglutide Has Beneficial Effects on Non-Alcoholic Steatohepatitis in Ldlr-/-.Leiden Mice
por: Inia, José A., et al.
Publicado: (2023)

Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis
por: Becker, Philip P., et al.
Publicado: (2015)

Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
por: Hattori, Sachiko, et al.
Publicado: (2021)

Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis
por: Hansen, Henrik H., et al.
Publicado: (2020)

Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
por: Hartmann, Phillipp, et al.
Publicado: (2022)

Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
por: Shiina, Shuichiro, et al.
Publicado: (2023)

Beneficial Effects of Fermented Green Tea Extract in a Rat Model of Non-alcoholic Steatohepatitis
por: Nakamoto, Kazuo, et al.
Publicado: (2009)

In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Kanuri, Giridhar, et al.
Publicado: (2013)

Is vitamin D receptor a druggable target for non-alcoholic steatohepatitis?
por: Cao, Ying, et al.
Publicado: (2020)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Vitamin D Status and Steatohepatitis in Obese Diabetic and Non-Diabetic Patients
por: Taban, Laura, et al.
Publicado: (2022)

Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis
por: Cook, Nigel, et al.
Publicado: (2020)

Ammonia Scavenger Restores Liver and Muscle Injury in a Mouse Model of Non-alcoholic Steatohepatitis With Sarcopenic Obesity
por: Wang, Zi-Xuan, et al.
Publicado: (2022)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Non-Alcoholic Steatohepatitis (NASH): Risk Factors in Morbidly Obese Patients
por: Losekann, Alexandre, et al.
Publicado: (2015)

An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
por: Matsumoto, Masahiko, et al.
Publicado: (2013)

MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model
por: Sakamoto, Hiroki, et al.
Publicado: (2021)

A fast and accurate mouse model for inducing non-alcoholic steatohepatitis
por: Rahimi, Shahrzad, et al.
Publicado: (2022)

The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Metabolomic Profiling to Identify Predictors of Response to Vitamin E for Non-Alcoholic Steatohepatitis (NASH)
por: Cheng, Jianfeng, et al.
Publicado: (2012)

Salt-Intake-Related Behavior Varies between Sexes and Is Strongly Associated with Daily Salt Consumption in Obese Patients at High Risk for MASLD
por: Heller, Bianca, et al.
Publicado: (2023)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Targeting acid ceramidase ameliorates fibrosis in mouse models of non-alcoholic steatohepatitis
por: Yu, Amy, et al.
Publicado: (2022)

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease
por: Jung, Finn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cni3m1tnhekncb9lpi5jviogab